Antioxidants in critical care medicine

Area of Science:

• Critical care medicine
• Biochemistry
• Pathophysiology

Background:

• Critically ill patients in the intensive care unit (ICU) experience high mortality despite advanced treatments.
• Reactive oxygen species (ROS) are implicated in the pathophysiology of organ dysfunction in various ICU conditions.
• ROS act as a common pathway for cell damage in acute respiratory distress syndrome (ARDS), central nervous system injuries, and post-subarachnoid hemorrhage ischemia.

Purpose of the Study:

• To review the role of ROS and antioxidant status in critically ill patients.
• To evaluate the efficacy of antioxidant therapies in improving survival in the ICU.
• To discuss the potential role of antioxidants within a comprehensive therapeutic approach.

Main Methods:

• Literature review and synthesis of existing research on ROS and antioxidant status in critical illness.
• Analysis of studies measuring total antioxidant status (TAS) and its correlation with patient survival.
• Examination of randomized clinical trials investigating antioxidant supplementation and free radical scavenging agents.

Main Results:

• High TAS levels correlate with improved survival in ICU patients, while low TAS is associated with poorer outcomes.
• Clinical trials supplementing endogenous antioxidant defenses have not shown clear survival benefits.
• Free radical scavenging agents have yielded mixed results in improving outcomes for critically ill patients.

Conclusions:

• The complex nature of critical illness and multi-organ pathologies makes single-component therapies, including antioxidants, unlikely to demonstrate clear efficacy alone.
• Antioxidant strategies should be considered as a component of a broader, rational therapeutic approach for critically ill patients.
• Further research may explore combination therapies or targeted antioxidant interventions within a multimodal treatment plan.